A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
Annals of oncology : official journal of the European Society for Medical Oncology(2014)
Abstract
NCT00231582.
MoreTranslated text
Key words
TAXIF II trial,germ-cell tumors,hematopoietic stem-cell transplantation,high-dose chemotherapy,nonrefractory patients
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined